
Dr Andrew Bond
B.Sc.(R'dg), Ph.D.(Lond.)
Expertise
I am a Lecturer in Cardiovascular Medicine, in Bristol Medical School, and Co-Director of MSc Cardiovascular Perfusion, and academic lead for the Heart & Valve Disease Units.
Current positions
Lecturer in Cardiovascular
Bristol Medical School (THS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
Research interests
My current research aims to develop a method of arterialising human saphenous veins (hSV) for use in coronary artery bypass surgery. An ongoing issue, with detrimental health and economic costs, is the development of thrombosis and lack of graft patency in 50% of autologous or synthetic venous grafts within 10 years of implant. Arterial conduits have been shown to remain patent in >95% of cases at 15-20 years post-bypass, and have improved long-term mortality rates. However, only ~20% of bypass grafts are performed using autologous arteries due to difficulties obtaining tissue and the likelihood of ageing-related arterial disease e.g. atherosclerosis. Using our bioreactor in vitro system, which allows us to perfuse the conduits at venous to arterial pulsatile pressures, we hope to develop cell seeding strategies and modify haemodynamic properties to turn decellularised hSVs into arteries for implant, which remain patent.
Following an 18-month change in research direction, developing methods to optimise islet cell transplantation in patients with Type I diabetes, this project returns to my scientific roots in cardiovascular research. My PhD at Imperial College London, and subsequent postdoctoral research in Bristol Heart Institute, focussed on changes in blood flow patterns, wall shear stress (haemodynamics), vessel wall mechanics and their effects on atherosclerosis development and atherosclerotic plaque rupture.
In Bristol, we are in the unique position of having the recently opened Translational Biomedical Research Centre (TBRC) for large animal work, and also have access to patient samples through the Bristol Royal infirmary and Bristol Children’s Hospital.
Projects:
- Arterial bioengineering of decellularised human saphenous veins to reduce early graft thrombosis and improve long-term patency rate
University of Bristol: June 2017-May 2020
- Right Ventricle Function in Children - RVENCH Study. A comparative study of the dysfunctional right ventricle in different congenital heart diseases
University of Bristol: September 2016-May 2017
- Manganese based contrast agents as markers of beta cell activity in a preclinical model of type 1 diabetes mellitus
University of Edinburgh: April 2016-June 2016
- Mesenchymal stromal cells for co-transplantation with human pancreatic islets to improve graft function
University of Edinburgh: November 2014-April 2016
- Vulnerable atherosclerotic plaques, foam cell phenotypes and extracellular proteinases
University of Bristol: April 2014-September 2014
- Pharmacological modulation of atherosclerotic plaque strength and plaque rupture
Roche Postdoctoral Fellowship/University of Bristol: March 2011-April 2014
- Vessel wall dynamics and plaque rupture
University of Bristol: February 2008-March 2011
- Effect of age and species on blood flow patterns at arterial branches in relation to atherosclerosis
PhD, Imperial College London: 2003-2007
Projects and supervisions
Research projects
Arterial bioengineering of decellularised human saphenous veins to reduce early graft thrombosis and improve long-term patency rate
Principal Investigator
Managing organisational unit
Bristol Medical School (THS)Dates
01/06/2017 to 31/05/2020
Publications
Recent publications
01/10/2024CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model
Atherosclerosis
FGL2/FcγRIIB signalling mediates arterial shear stress-mediated endothelial cell apoptosis: implications for coronary artery bypass vein graft pathogenesis
International Journal of Molecular Sciences
Intra-myocardial immunomodulation with human CD16+ monocytes to treat myocardial infarction in pig:
Frontiers in Cardiovascular Medicine
The effect of cardioplegic supplementation with sildenafil on cardiac energetics in a piglet model of cardiopulmonary bypass and cardioplegic arrest with warm or cold cardioplegia
Frontiers in Cardiovascular Medicine
Development and Preliminary Testing of Porcine Blood-Derived Endothelial-like Cells for Vascular Tissue Engineering Applications
International Journal of Molecular Sciences